WHO preferred product characteristics for group B streptococcus vaccines
dc.contributor.author | World Health Organization | |
dc.coverage.spatial | Geneva | en_US |
dc.date.accessioned | 2017-08-10T16:17:17Z | |
dc.date.available | 2017-08-10T16:17:17Z | |
dc.date.issued | 2017 | |
dc.identifier.govdoc | WHO/IVB/17.09 | |
dc.identifier.uri | https://iris.who.int/handle/10665/258703 | |
dc.description | 17 p. | en_US |
dc.language.iso | en | en_US |
dc.publisher | World Health Organization | en_US |
dc.rights | CC BY-NC-SA 3.0 IGO | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/3.0/igo | en_US |
dc.subject.mesh | Streptococcus agalactiae | en_US |
dc.subject.mesh | Vaccines | en_US |
dc.subject.mesh | Infant | en_US |
dc.title | WHO preferred product characteristics for group B streptococcus vaccines | en_US |
dc.type | Technical documents | en_US |
dc.rights.holder | World Health Organization | en_US |